Delivery Order SPE2DE23D0008-SPE2D625F0ZZQ
Award Date 8/14/25
Potential Completion Date 8/18/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $1,495.00 for Natrelle TE Smooth 133S-MX-14-T breast implants. This fixed-price contract with economic price adjustment was awarded on November 20, 2025, with an ultimate completion date of November 24, 2025, and will be performed in Irvine, California. The contract was funded by the Medical Supply Chain division of the Defense Logistics Agency and carries no set-aside designation, reflecting Allergan's...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,495 fixed-price delivery order (contract number 4570063968) for Natrelle TE Smooth 133S-MV-15-T breast implants on November 20, 2025, with an ultimate completion date of November 24, 2025. The award was made without a set-aside designation and will be performed in Irvine, California. Funding is provided by the Medical Supply Chain division of the Defense Logistics Agency Troop Support Medical, which procures specialized surgical...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,990 delivery order by the Defense Logistics Agency Medical Supply Chain on September 5, 2025, for Natrelle TE Smooth 133S-MX-13-T breast implants. The contract is a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of September 9, 2025. This award was made without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical implants....
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $2,990.00 for Natrelle TE Smooth 133S-MV-14-T breast implants under a fixed-price contract with economic price adjustment. The award was issued on September 11, 2025, with an ultimate completion date of September 25, 2025, and carries no set-aside designation, reflecting Allergan's status as a sole-source provider of these specialized medical devices. The product will be delivered to Irvine, California,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $3,404.00 for Natrelle TE Smooth 133S-MX-14-T breast implants on July 24, 2025. This delivery order, issued without set-aside designation, represents a child contract under Allergan's larger Indefinite Delivery Vehicle (IDV) agreements with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is funded through the Medical Supply Chain division of DLA and involves fixed-price...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order on September 19, 2025, for Natrelle Inspira SCM 445CC breast implants through the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract carries an ultimate completion date of September 23, 2025, and will be performed in Irvine, California. This delivery order was issued without set-aside designation, reflecting Allergan's sole-source supplier status for specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,021.00 fixed-price delivery order with economic price adjustment for Natrelle Inspira SCM 375CC breast implants on July 22, 2025. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, will be performed in Irvine, California and is scheduled for completion by July 24, 2025. The contract was awarded without set-aside designation by the Medical Supply Chain division of the Defense Logistics...
- Allergan USA Inc., a subsidiary of AbbVie Inc., received a $9,109 fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical on June 26, 2025, for Natrelle TE Smooth 133S-MV-11-T breast implants. This delivery order, which carries no set-aside designation, is scheduled for completion by June 30, 2025, with performance to be executed in Irvine, California. The award represents a child contract action under one of Allergan's two significant Indefinite Delivery...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division for 4569553905 Inspira SRF 385CC breast implants, valued at $1,110.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 25, 2025, and represents performance work to be completed at Allergan's facility in Irvine, California. The award utilizes no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814 fixed-price delivery order for Natrelle Inspira SCM 330cc breast implants by the Defense Logistics Agency (DLA) Troop Support Medical on September 5, 2025. This delivery order, which has no set-aside designation, is a child contract stemming from one of Allergan's larger Indefinite Delivery Vehicles—specifically the $13.5 million Natrelle breast implants and surgical devices IDV established on December 8, 2022. The order is...